This inventor holds 7 USPTO granted patents. Top assignee: Parker Hughes Institute. Active years: 2002-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- St. Anthony, MN (US) (2002 - 2003)
- Maplewood, MN (US) (2004 - 2005)
Company Filing History:
Years Active: 2002-2005
Title: **Innovator Spotlight: Taracad K Venkatachalam**
Introduction
Taracad K Venkatachalam is a notable inventor based in Maplewood, Minnesota, renowned for his significant contributions to the field of pharmaceuticals. With a portfolio of seven patents, he stands out as a leading figure in the development of innovative compounds aimed at combating various strains of HIV.
Latest Patents
Among his latest inventions are two remarkable patents that showcase his expertise and commitment to advancing medical science. The first is focused on "Adamantyl Thiazole Thioureas," which discloses novel aromatic and heterocyclic thiazolyl thiourea compounds. These compounds serve as effective agents in the treatment of HIV infection, particularly against non-nucleoside inhibitor-resistant and multi-drug resistant strains of the virus.
The second patent involves "Aryl phosphate derivatives of d4T with potent anti-viral activity." This innovation describes methods for enhancing the elimination half-life of key metabolites such as d4T. By administering an aryl phosphate derivative of d4T with specific substituents, the administration of HI-113 has been found to result in prolonged systemic exposure to crucial metabolites, demonstrating significantly longer elimination half-lives in vivo.
Career Highlights
Taracad K Venkatachalam is currently affiliated with the Parker Hughes Institute, where he continues to pursue groundbreaking research and development in his field. His work not only highlights his inventiveness but also reflects his dedication to finding solutions for some of the most pressing health challenges.
Collaborations
Throughout his career, Taracad has collaborated with esteemed colleagues such as Fatih M Uckun and Osmond D'Cruz. These partnerships have fostered creative solutions and innovative ideas that contribute to the advancement of pharmaceutical research.
Conclusion
Taracad K Venkatachalam's impressive track record of patents underscores his impact as an inventor in the pharmaceutical industry. His dedication to developing new treatments for HIV exemplifies the ongoing importance of innovation in medicine. As he continues his work at the Parker Hughes Institute, the potential for future breakthroughs remains promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile